欢迎来到《四川大学学报(医学版)》
许建屏, 石应康, 董力等. 中国人心脏瓣膜置换术后低强度抗凝治疗3 000例随访1年报告[J]. 四川大学学报(医学版), 2016, 47(1): 90-92.
引用本文: 许建屏, 石应康, 董力等. 中国人心脏瓣膜置换术后低强度抗凝治疗3 000例随访1年报告[J]. 四川大学学报(医学版), 2016, 47(1): 90-92.
XU Jian-ping, SHI Ying-kang, DONG Li. et al. Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement——3 000 Cases Follow-up[J]. Journal of Sichuan University (Medical Sciences), 2016, 47(1): 90-92.
Citation: XU Jian-ping, SHI Ying-kang, DONG Li. et al. Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement——3 000 Cases Follow-up[J]. Journal of Sichuan University (Medical Sciences), 2016, 47(1): 90-92.

中国人心脏瓣膜置换术后低强度抗凝治疗3 000例随访1年报告

Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement——3 000 Cases Follow-up

  • 摘要: 目的 研究中国人心脏瓣膜置换术后早期低强度抗凝的疗效。方法 对2011年1月至2012年3月间,北京阜外医院成人心脏中心和四川大学华西医院心外科有完整住院资料的3 000例瓣膜置换术后患者随访1年,分析抗凝治疗强度、方法及并发症等指标。结果 共2 657例获随访,随访率88.57% ,随访总量1 726.1患者/年(Pty)。 华法林剂量0.625~12.0(2.68±6.45) mg/d;阜外医院国际标准比值(INR)实测均值为2.01±1.10, 华西医院1.86±0.69,两院间实际抗凝强度(INR均值1.8~2.0) 相似,差异无统计学意义(P=0.28)。抗凝总并发症发生及死亡率分别为5.79% Pty与0.12% Pty;其中出血发生及死亡率分别为3.59% Pty与0.12% Pty;严重性出血发生及死亡率分别为0.29% Pty与0.12% Pty;栓塞发生及死亡率分别为2.03% Pty与0.00% Pty,血栓形成发生及死亡率分别为0.29% Pty与0.00% Pty。 结论 中国人心脏瓣膜置换术后采用低强度抗凝治疗(INR 1.5~2.5),取得了栓塞与血栓并发症发生率无明显增加,出血并发症发生及死亡率明显降低的疗效。 国人抗凝治疗强度并无明显地域差别。

     

    Abstract: Objective To investigate the effect of low-intensity anticoagulation therapy for Chinese population with heart valve replacement. Methods From January 2011 to March 2012, 3 000 patients with heart valve replacement in Fuwai Hospital and West China Hospital were followed-up for 1 year, the method and intensity of postoperative anticoagulation, as well as the complications were studied and analyzed. Results The rate of follow-up was 88.57%, and the cumulative follow-up was 1 726.1 patient-years (Pty). The mean oral warfarin dosage was (2.68±6.45) mg/d, and the mean INR values of the patients treated in Fuwai Hospital and West China Hospital were 2.01±1.10 and 1.86±0.69 respectively (total 54 379 samples).The total rates of anticoagulation complication and mortality were 5.79% Pty and 0.12% Pty respectively, among which the morbidity and mortality of hemorrhage were 3.59% Pty and 0.12% Pty respectively, while the morbidity and mortality of thromboembolism were 2.03% Pty and 0.00% Pty respectively. There are no significant differences of actual anticoagulation intensity (P=0.28)and the complication rates between the two hospitals .Conclusion The optimal intensity scope (INR) of 1.5-2.5 (mean 1.8-2.0) is safe and efficient for Chinese patients with prosthetic heart valves, and no significant regional difference in the intensity of anticoagulation therapy required.

     

© 2016 《四川大学学报(医学版)》编辑部 版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回